Immunome Announces Data Demonstrating COVID-19 Antibody Cocktail Potently Clears Omicron BA.1 Variant in Hamster Model and Retains Activity Against BA.2 Subvariant

Data show that combination of two antibodies in Immunome’s cocktail successfully neutralized the Omicron variant in vivo in hamsters 

IMM20253 antibody also retained activity against BA.2 subvariant in pseudovirus testing in vitro, with additional testing underway 

See more here


Renovacor Reports First Quarter 2022 Financial Results and Provides Corporate Update

REN-001 advancing toward IND submission in the second half of 2022 with the initiation of a Phase I/II clinical trial in BAG3-DCM expected thereafter

Strengthened executive team with appointment of Fred Driscoll as CFO

See more here


Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results

See more here


Annovis Bio Announces First Quarter 2022 Results and Provides Corporate Update

See more here


Relmada Therapeutics Announces Publication of REL-1017 Preclinical Data in Frontiers in Pharmacology

See more here


Scripps Health and UT Health San Antonio purchase Oncora’s software to improve physician documentation and enhance personalized cancer care

See more here


Melior Announces Substantial Additions to Its Management and Scientific Team 

• Dr. Ken Kilgore joins Melior as VP of Scientific Operations

• Dr. Hongyan Li joins Melior as Director of Oncology

• Dr. Vivian Cong rises to VP of Research & Development

See more here


WellTrackONE Corporation releases Targeted Risk Adjustment Coding system (TRAC)

TRAC will help with HCC RAF scores, lost revenue opportunities and avoidance of RAC/RADV audit penalties

See more here


Venatorx Pharmaceuticals Raises Series C Financing Led by the AMR Action Fund

See more here